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Microvascular and clinical effects of altered peritoneal dialysis
solutions. Blood flow in the peritoneum is one of the more impor-
tant factors governing the efficiency of peritoneal dialysis. Yet
there have been no previous studies which relate alterations and
control of the peritoneal microcirculation to dialysis efficiency.
Thus, we used closed-circuit television microscopy to quantitate
the in vivo response (changes in diameter) to dialysis solutions of
the small arteries on the mesothelial surface of the rat cecum and
arterioles of the rat cremaster muscle. These responses were cor-
related with solute clearances from multiple peritoneal dialysis
performed in humans. In the cremaster, a transient constriction
was followed by a prolonged dilation. pH adjustments of the dial-
ysis solution from 5.6 to 7.4 had no effect on the microvascular
response and no effect on solute clearances during human perito-
neal dialysis. In the cecum, dialysis solution caused a prolonged
dilation which reached a maximum in about 10 mm. Since dila-
tion appears to be an important determinant of solute clearances
during human peritoneal dialysis, the effects of a vasodilator, so-
dium nitroprusside, were determined. Sodium nitroprusside de-
creased the time to maximal dilation, which correlated clinically
with an increased solute clearance during exchanges with this
drug. Since nitroprusside increased clearances of the larger mo-
lecular weight solutes proportionally more than the smaller mo-
lecular weight solutes did, we hypothesize that nitroprusside in-
creases solute clearances by both a vasodilatory effect and by an
effect on vascular membrane permeability and area for solute ex-
change.
Effets microvaseulaires et cliniques de solutions de dialyse pen-
tonéale modiflees. Le debit sanguin dans le peritoine est l'un des
facteurs les plus importants qui gouvernent l'efficacite de Ia dial-
yse peritonCale. II n'y a pas eu, cependant, d'étude de Ia relation
entre les modifications et Ic contróle de la microcirculation pen-
tonCale, d'une part, et l'efficacitd de la dialyse, d'autre part.
Nous avons utilisé l'observation microscopique par l'intermédi-
aire d'un circuit de télévision pour quantifier Ia response in vivo
(modifications de diamètre) aux solutions de dialyse des petites
artères de Ia face mdsothéliale du coecum de rat et des arterioles
du muscle crémastérien de rat. Ces réponses ont ete corrClées
avec les clearances de solutés observées an cours de nom-
breuses dialyses peritonCales réalisées chez l'homme. Dans Ic
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crémaster une constriction transitoire est suivie par une dilata-
tion prolongCe, Les ajustements du pH de Ia solution de 5,6 a
7,4 n'ont pas d'effet sur Ia rCponse microvasculaire et n'ont
pas d'effet sur les clearances des solutCs qui sont mesurées au
cours de Ia dialyse péritonCale chez l'homme. Dans le coecum
Ia solution de dialyse determine une dilatation prolongée qui
atteint un maximum en 10 minutes environ. Du fait que Ia dilata-
tion parait Ctre un determinant important des clearances des
solutCs qui sont mesurCes au cours de la dialyse peritonéale,
chez l'homme, les effets d'un vasodilatateur, le nitroprusside de
sodium, ont Cté étudids. Le nitroprusside de sodium diminue
Ic temps nécessaire pour atteindre une dilatation maximale,
cela est corrélé avec une augmentation de Ia clearance des sub-
stances dissoutes au cours des échanges réalisés avec cet agent.
Du fait que le nitroprusside augmente les clearances des solutCs
de poids moléculaires les plus élevés proportionnellement plus
que celles des solutds de poids moléculaires faibles nous avons
fait l'hypothèse que Ic nitroprusside augmente les clearances
des solutés qui sont mesurées au cours de in dialyse pénitonéale
chez l'homme a Ia fois par un effet vasodilatateur et par un effet
sur Ia permCabilité de Ia membrane vasculaire etJou Ia surface
d'echange.
Peritoneal dialysis has been used as a treatment
for uremia for over 50 years. Only recently, how-
ever, with the technical success of new catheters
and of home peritoneal dialysis procedures, has it
gained measurable acceptance. Consequently, the
solutions used for dialysis and their effects on solute
transport and solute delivery, two principal physio-
logic determinants of dialysis efficiency, have had
little scientific evaluation. Commercial peritoneal
dialysis solutions contain several factors that may
be vasoactive and affect solute delivery, such as a
low pH, a high osmolality, lactate or acetate, and a
high dextrose concentration. In addition, recent
clinical studies by Nolph et al [1] and animal studies
by Brown et al [2] have indicated that addition of
vasodilators to dialysis solutions can further in-
crease the peritoneal clearances of urea, inulin,
creatinine, and protein.
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Since dialysis solutions will contact many dif-
ferent tissues in the peritoneum, we chose two rep-
resentative tissues for experimentation. In vivo ml-
crovascular experiments were performed on arteri-
oles of the rat cremaster (a model for parietal
peritoneum) and on small arteries on the mesothe-
hal surface of the rat cecum (a model for visceral
peritoneum). The initial experiments in this investi-
gation were designed to determine if peritoneal dial-
ysis solutions were vasoactive. We used three com-
mercial peritoneal dialysis solutions and correlated
the human clearances during dialysis with effects on
the rat microcirculation. These experiments pro-
vided the first demonstration of the vasoactive
properties of peritoneal dialysis solutions. Because
others have shown profound effects of acidity on
vasoactivity of drugs and on microcirculatory con-
trol mechanisms [3] and these solutions are acidic
(pH, 5.2 to 5.8), we also determined the effects of
pH adjustment of dialysis solution to 7.4 both on
human peritoneal dialysis clearances and on the rat
microcirculation. Last, in an attempt to determine
the mechanism by which vasodilators enhance
clearances during dialysis, the microvascular ef-
fects of nitroprusside in dialysis solution were cor-
related with data from human peritoneal dialyses.
Methods
Rat microcirculation. Four groups of Sprague-
Dawley rats (each weighing 134 to 158 g) were used
in these studies, and all animals were anesthetized
with an intraperitoneal injection of a combination of
a-choraiose (60 mg/kg) and urethane (800 mg/kg).
The surgical preparation of the cremaster muscle
that we used has been previously described in detail
[4]. The cremaster is a skeletal muscle that is de-
rived from the internal abdominus oblique, one of
the abdominal wall muscles which surround the
peritoneum. Essentially, the right cremaster was
slit along its midline, keeping major nerves and the
circulation to the animal intact. The cremaster was
spread with sutures over a cover glass in the bottom
of a 60-mi plexiglass bath, which was filled with a
modified Krebs solution containing 118.5 mivi so-
dium chloride, 19.9 m sodium bicarbonate, 11.6
m dextrose, 4.7 m potassium chloride, 2.5 mM
hydrated calcium chloride, 1.2 mrvi monobasic po-
tassium phosphate, and 1.2 m hydrated magne-
sium sulfate. Bath temperature was controlled at
3450 C by means of an immersed insulated heating
coil. pH of the bath was maintained at 7.4, and Pco2
at 40, by bubbling carbon dioxide into the Krebs
solution. The rat was positioned on a microscope
stage so that light could be passed through the cover
glass and cremaster muscle into the microscope ob-
jective. Closed-circuit television microscopy was
used to project the image of a small arteriole onto a
television monitor, and the diameter of this vessel
was measured every 30 seconds with a millimeter
ruler. Arterioles, 7.6 to 16 m in diameter, exhib-
iting vasomotion, a rhythmic alternating vasocon-
striction and vasodilation, were used in these exper-
iments. The rat cecum preparation was essentially
the same as the cremaster. The cecum was exteri-
orized, split along its midline, and spread over the
optical port in the tissue bath. The diameter of a
small artery (approximately 75 m) on the meso-
thelial surface of the cecum was measured by an
automated device previously developed in our lab-
oratory [5]. Peristaltic movement and the thickness
of the cecum made it difficult to measure the ves-
sels of the same size used in the cremaster prepara-
tion. Bath temperature for this preparation was
maintained at 37° C.
The left femoral artery was cannulated for mea-
surement of mean arterial pressure, and small sub-
cutaneous needle electrodes were used to obtain an
electrocardiogram for heart rate calculations. Blood
pressure and heart rate were recorded every min-
ute. Rectal temperature was maintained by a small
heating pad placed under the animal.
In group R-I (N = 5), the effects of three com-
mercial 1.5% dextrose peritoneal dialysis solutions,
McGaw® (McGaw), Inpersol® (Abbott), and Dia-
neal® (Travenol), were examined. Potassium chlo-
ride, 3.0 mEq/hiter, was added to these and to all
other dialysis solutions used in this study. The com-
position of these solutions is shown in Table 1. Data
was collected for a 5-mm control period, during
which the Krebs solution bathed the cremaster, and
for a 10-mm experimental period which followed
draining of the bath and addition of one of the dial-
ysis solutions. The bath was then changed every 5
mm with a fresh Krebs solution for a recovery peri-
od of at least 15 mm, during which time the vessels
returned to control diameters. This protocol, with
random sequencing, was repeated for a single ves-
sel in each animal with each of the three solutions
so that the effects of all solutions on the same vessel
were observed.
In group R-II (N = 5), we determined the micro-
circulatory effects of the Abbott solution (In-
persol®) with the additions of nitroprusside, or pH
adjustment (by the addition of sodium hydroxide),
or both. The protocol was the same as that used for
group R-I. Four sequences were used in each ani-
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Table 1. Composition of Krebs and peritoneal dialysis solutions
Krebs McGaw®a Dianeal®a Jnpersol®a.b
Glucose,glliier 2.1 15 15 15
Sodium, mEqiliter 138 140 145 132
Calcium,mEq/liter 5.1 4 4 3.5
Magnesium,mEq/liter 2.4 1.5 1.5 1.5
Chloride, mEqiliter 128 103 103 102
Sulphate, mEqiliter 2.4 — — —
Potassium, mEqiliter 3.1 3 3 3
Phosphate,mEqlliter 1.2 — — —
Lactate, mEqiliter — — 45 35
Acetate,mEqlliter — 45 — —
Bicarbonate, mEqiliter 19.9 —
Bisulfite,mEq/liter <1 <1 2.9
Osmolality, mOsmlkg H/i 285 352 347 334
pH 7.4 5.8 5.3 5.8
Pco2,mmHg 40 <10 <10 <10
Po2, mm Hg 30 to 40 30 to 40 30 to 40 30 to 40
pH adjustment to 7.4 increased osmolality approximately 5 mOsm/kg H20,b ThePo2 of Inpersol® was frequently 5 to 10mm Hg below this range. The values for the drainage solutions of Inpersol® used in group
R-IV were: pH, 7.2; P02, 35 to 45 mm Hg; Pco2, 40 to 50 mm Hg.
ma! with the following four solutions; (A) control
Inpersol®, pH = 5.8; (B) Inpersol®, pH adjusted to
7.4 with sodium hydroxide; (C) solution A, plus the
addition of 1.5 X lO M sodium nitroprusside, pH
= 5.8; and (D) solution B plus the addition of 1.5 X
lO- M sodium nitroprusside, pH = 7.4.
In a third group (R-III) of rats (N = 5), the effects
of pH-adjusted McGaw® solution, without and
with sodium nitroprusside, 1.5 X 1O M, were de-
termined on small arteries in the cecum. In these
experiments, the effects of the solutions were ob-
served for 45 mm to determine if the responses were
maintained or waned during a solution exposure pe-
riod similar to that present in our human peritoneal
dialyses.
This concentration of sodium nitroprusside is the
same as that used in the clinical experiments. In ad-
dition, it is the mean maximally effective concentra-
tion for dilation of small arterioles, as determined
by two concentration-response curves in each of
nine rats.
The protocol for group R-IV (N = 6) was the
same as it was for groups R-I and R-II, except that
dialysis drainage solutions (from one patient who is
described later in the clinical section) were used in-
stead of fresh solutions. This series of experiments
was performed to determine if the microvascular ef-
fects of the dialysis solutions were changed during
dwell in the human peritoneum.
Clinical studies. These studies were approved by
the University of Missouri Committee for Research
Involving Human Subjects. All peritoneal dialyses
were performed in patients with primary renal dis-
ease and virtually no renal function. None were hy-
pertensive at the time of the studies or known to
have any systemic disease involving the peritoneal
vasculature. A peritoneal dialysis exchange con-
sisted of a 10-mm period for instillation of dialysis
solution, a 30-mm dwell period of the dialysis solu-
tion in the peritoneum, and a 20-mm drainage peri-
od. In the first group of five patients (C-I), clear-
ances of urea, creatinine, and inulin and concentra-
tions of protein were determined from exchanges
using 1.5% dextrose dialysis solutions of McGaw®,
Inpersol®, and Dianeal®. Each patient had at least
12 exchanges of each of these three solutions.
Drainage volume was measured for each exchange
and used in the calculation of protein concentra-
tions and urea, creatinine, and inulin clearances.
Blood pressure and heart rate were monitored peri-
odically throughout the exchanges.
In a second group (C-Il) of four patients, In-
persol® solutions A, B, C, and D (as described
above for the rat microcirculatory experiments)
were instilled into the peritoneal cavity, and solute
clearances and concentrations of protein were de-
termined. The study in the first patient was con-
ducted 1 day/week for 4 weeks. It was designed to
determine if the order of administration of the solu-
tions would have an effect on solute clearances. On
each day, after a series of washout exchanges with
solution A (no data collection), one of four Se-
quences(A, B, C, D; B, C, D, A; C, D, A, B; and D,
A, B, C) were used with 3 consecutive exchanges of
each solution. Thus, over the 4 days a total of 48
exchanges were performed, 12 for each solution.
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The drainage from these dialyses were collected,
pooled, and used for the drainage solutions of group
R-IV rats.
In the other three patients, in 1 day, 24 exchanges
were performed, 6 consecutive exchanges for each
of the four solutions. Blood samples were drawn pe-
riodically throughout all studies, and extrapolated
blood concentrations from a linear regression curve
were used to calculate clearances by the formula
(drainage volume/time) x (dialysate concentration!
serum concentration). Urea and creatinine concen-
trations were determined with the Technicon
Autoanalyzer IL Inulin was measured by the meth-
od of Walser, Davidson, and Orloff [6]. Protein was
determined by the method of Westgard and Po-
quette [7].
The data from each patient was averaged to give a
single value for each solute. These values for the
four patients were combined to give a group aver-
age (N = 4) for all solutes except protein which was
measured in only three patients.
All human and rat data is presented as the means
SEM. Student's t tests, analysis of variance, and
multiple range tests with adjustment for unequal N
size [8] were used to determine statistical signifi-
cance (P < 0.05).
Results
Microcirculation studies. The effects of topically
applied peritoneal dialysis solutions on the diameter
of a small arteriole in the cre master of one rat from
group R-I are shown in Fig. 1. McGaw®, In-
persol®, and Dianeal® all produced a transient
constriction of this vessel. This short response (usu-
ally lasting less than 2 mm) was followed by a sus-
tained dilation for the remainder of the experimen-
tal period. During the 15-mm recovery period (wash
with Krebs solution every 5 mm), the vessels re-
turned to near control diameters. Mean control di-
Table 2. Effects of three topically applied dialysis solutions on
the diameters of small arterioles in the rat cremaster (group Rl)a
Inpersol® McGaw® Dianeal®
Control diameter, pm 8.6 0.8 7.7 0.9 8.3 0.6
Minimal diameter, pm 3.6 1.0" 2.2 Ø•6b 3.3 0.9"
Maximal diameter, pm 23.8 3.4" 24.0 45b 24.2 3.2"
a Data are the mean SEM.
b P < 0.05, for the comparison to control diameter.
ameters and mean responses of group R-I are pre-
sented in Table 2. Mean control diameters for the
arterioles in this group were similar in the three se-
quences (range, 7.7 to 8.6 .tm). With the application
of each solution, there was a significant vasocon-
striction (minimal diameter) followed by vasodila-
tion (maximal diameter). The responses (con-
striction and dilation) were not different among the
three solutions, and there was no apparent effect of
the order in which these sequences were per-
formed. When the bath was changed with fresh
Krebs solution, there were no significant micro-
vascular effects. This indicates that factors such as
changes in Po2, Pco2, temperature, or physical
stress can not account for the observed responses
to the dialysis solutions. In addition, these topically
applied solutions did not alter mean arterial blood
pressure or heart rate, thus precluding a systemic
influence on the arteriolar responses.
Because the three brands of peritoneal dialysis
solutions used in group R-I gave similar results, a
single brand, Inpersol®, was arbitrarily chosen for
further study. The effects of this solution with and
without pH adjustment to 7.4 and with and without
addition of sodium nitroprusside (1.5 x l0- M)
were determined in each of the five animals in group
R-II. This nitroprusside concentration was chosen
because it gave a maximal effect in the rat arterioles
and because our calculations indicated it to be a
safe clinical dose for intraperitoneal administration.
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Fig. 1. Data for one experiment from group R-I. A 5-mm control period with Krebs solution
bathing the cremaster was followed by a 10-mm exposure to a peritoneal dialysis solution and
then a 15-mm wash period with Krebs solution. This cycle was repeated for each dialysis solu-
tion in each experiment.
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Fig. 2. Data for one experiment from group R-II. The protocol
for a small arterial in the cremaster was the same as that in-
dicated in Fig. 1 except that inpersol® (control solution A) and
three modifications of Inpersol® (B, C, and D) were used after
the Krebs control periods.
The microvascular effects of Inpersol® (control so-
lution A) and our three modifications of Inpersol®
are shown in Fig. 2 as an example of data from one
animal. Data for all of group R-II is presented in the
top panel of Table 3. Inpersol® (control solution A)
caused an initial constriction to 5.5 0.8 m from a
control diameter of 10.9 1.3 j.tm. This was fol-
lowed by a prolonged dilation to 26.8 2.8 jxm. pH
adjustment to 7.4 (solution B) had no effect on these
responses. With solutions C (control A plus 1.5 X
10 M sodium nitroprusside) and D (pH adjusted to
7.4 plus 1.5 x l0 M sodium nitroprusside), there
was no initial constriction, but instead there was an
immediate and sustained dilation to 28.3 1.8 and
27.4 1.5 xm, respectively. Maximal arteriolar di-
lation in all four solutions were not significantly dif-
ferent from each other. pH adjustment, or the addi-
tion of sodium nitroprusside to the bath, or both had
no significant effect on heart rate or mean arterial
blood pressure during any of the of the four se-
quences.
The lower panel of Table 3 shows the micro-
circulatory results for group R-IV. All solutions (A,
B, C, and D) showed effects on the rat micro-
vasculature after drainage from the human perito-
neal cavity which were indistinguishable from the
effects that they had before instillation (group R-II).
For all solutions, the pH reflects the effect of an
hour equilibration in the human peritoneal cavity.
Thus, during the exchanges, the pH of solutions A
and C increased from 5.8, and the pH of solutions B
and D slightly decreased from 7.4.
The effects of topically applied, pH-adjusted,
McGaw® solution on the small mesothelial arteries
of the cecum are shown as a percent of the control
diameter in Krebs solution in Fig. 3. After the dial-
ysis solution was added to the bath, the vessels di-
Table 3. Effects of fresh dialysis (group R-lH) and drainage (group R-IV) solutions on the diameters of small arterioles in the rat
cremaster
Solutions pH
Control di
/.M
ameter Minimal diameter
/LM
Maximal diameter
LM
Group R-lI
A(controllnpersol®) 5.8 0.05 10.9 1.3 5.5 0.8 26.8 2,8b
B (pH-adjusted
control) 7.4 0,04 8.7 1.0 4.7 0.7k' 24.2 32b
C (control plus
nitroprusside) 5.8 0.03 10.4 1.4 — 28.4 1,gb
D (pH-adjusted control
plus nitroprusside) 7.4 0.03 10.9 1.1 — 27.4 l.5'
Group R-1V
A(controllnpersol®) 7.18 0.02 11.1 1.3 5.6 0.9 25.9 2.3
B (pH-adjusted
control) 7.16 0.02 10.8 1.5 7,3 l.8 25.5 2.3
C (control plus
nitroprusside) 7.17 0.02 9.2 1.6 — 25.6 2.5"
D (pH-adjusted control
plus nitroprusside) 7.16 0.01 10.8 1.1 — 27.6 2.1"
a These solutions were equilibrated with a 60-mm exchange in the human peritoneum before topical application to the cremaster
vasculature. pH values reflect this equilibration.
"P < 0.05, paired t-test comparison with control diameter.
Dashes indicate that no constriction was observed.
A
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Fig. 3. Group R-III data plotted as percent of control diameter.
A 10-mm control period with Krebs solution bathing the cecum
was followed by a 45-mm exposure to peritoneal dialysis solution
alone (dotted line) or peritoneal dialysis solution with 1.5 x 10
M sodium nitroprusside (solid line).
lated, reaching a maximum in about 10 mm. Mean
small artery diameter increased from 77.0 4.9 sm
during control to 97 4.2 jsm in the presence of
dialysis solution. They remained dilated for the en-
tire period but returned to control values when the
bath was changed back to Kreb's solution.
In the presence of nitroprusside, maximal dilation
6
a,U
0
appeared to occur earlier (at 2 mm). Although there
was a trend towards a greater maximal effect, ves-
sels dilated from a control of 74 5.1 em to 100
0.4 m with nitroprusside, the differences with and
without nitroprusside were not significant.
Clinical studies. Figure 4 shows the results for
the comparison of the three commercial dialysis so-
lutions in solute clearances and concentration of
protein (group C-I). As was seen for the rat micro-
circulation, the three brands gave no differences in
the measured parameters.
The peritoneal dialysis solutions used in the mi-
crocirculatory studies, Inpersol®, with and without
pH adjustment and with and without nitroprusside,
were instilled repeatedly in four patients (group C-
II), and solute clearances were determined. In the
first patient, the protocol was designed to illuminate
any effect of order of administration on solute clear-
ances. There were, however, no trends that in-
dicated that the order of instillation of the four solu-
tions influenced the solute clearances. Clearance
data for each solution in each of the four patients
are shown in Table 4. Data were normalized to ac-
count for the substantial differences in clearances
for control solution A (Inpersol®) and plotted in
Fig. 5 as a percent of solution A. These data in-
dicate that pH adjustment of dialysis solution from
5.8 to 7.4 (solutions A vs. B) does not effect the
145
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Fig. 4. Clearances (mean SEM) of urea, creatinine, and inulin and concentrations of protein.
Data are from multiple 60-mm exchanges in five patients using 1.5% dextrose dialysis solutions
of McGaw®, Inpersol®, and Dianeal®.
Dianeal lnpersol McGaw
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Table 4. Effects of pH adjustment and sodium nitroprusside addition on solute clearances during peritoneal dialysis of four patientsa
Urea, mi/mm Creatinine, mi/mm Inulin, mi/mm
A
Protei
B
n, mg/dl
C DPatient no. A B C D A B C D A B C D
1 19.2 20.0 25.0 23.2 16.5 17.4 21.6 19.6 8.6 8.1 11.5 11.1 — — — —
2 19.1 19.9 21.3 23.3 16.8 18.4 17.1 20.7 4.0 4.7 4.4 5.9 67 84 91 181
3 18.8 21.1 21.1 24.4 12.9 12.6 17.0 17.9 3.2 2.9 3.7 5.5 38 39 60 124
4 12.9 12.9 14.4 16.5 13.2 14.6 14.9 16.3 2.9 3.2 3.8 4.1 48 43 90 91
a Each value represents the mean clearance of all exchanges for each patient with each solution: A, control Inpersol®, B, pH adjusted
to 7.4; C, addition of 1.5 x l0 M sodium nitroprusside; D, pH adjusted to 7.4 plus 1.5 x 10 M sodium nitroprusside.
clearances of urea, creatinine, or inulin, or the con-
centration of protein. There was, however, a signifi-
cant (P < 0.05) increase in clearances of urea,
creatinine, and inulin with the addition of sodium
nitroprusside to the control solution (solution A vs.
C). Clearances and protein concentrations were al-
so significantly greater (P < 0.05) in solution D (ni-
troprusside plus pH adjustment) than they were in
solution A. In addition, the mean clearance for each
solute appeared greater in D than it did in C, in-
dicating a possible interaction of sodium nitro-
prusside and pH adjustment to increase clearances.
Because there were no significant effects of sodium
nitroprusside on heart rate or blood pressure, it is
C0
C
C(I)
C
C0
C.,
0
C
U
a-
unlikely that sufficient nitroprusside entered the
systemic circulation to produce cardiovascular ef-
fects that could have influenced these results. Also,
the volumes (mean SEM) of the drainage solutions
were not significantly different, 2082 37 ml (A),
2172 26 ml (B), 2106 48 ml (C), and 2167 72
ml (D). Thus, it is unlikely that differences in ultra-
filtration alone could explain the observed dif-
ferences in clearances.
Dialysis with nitroprusside in the solution was al-
so accompanied by a decrease in the dialysate glu-
cose concentration (1011 75 mgIlOO ml in solution
A, and 1031 64 mgIlOO ml in solution B, com-
pared to 944 47 mg/100 ml in solution C and 917
300
200
A Control (pH = 5.6)
B = pH adjusted (pH = 7.4)
C Nitroprusside (pH 5.6)
D = pH adjusted and nitroprusside (pH = 7.4)
* P <0.05
*
*
A B CD A B CD A BC 0
Urea Creatinine Inulin
160 daftons( (113 daltons) (5000 daltons)
Clearances, rng/100 ml
Fig. 5. Clearances of urea, creatinine, inulin, and concentrations of protein from four patients
with multiple 60-mm exchanges. Values (means 5EM) are plotted as a percent of control (the
mean clearance or concentration determined in solution A, control Inpersona). An asterisk
indicates a significant difference (P < 0.05) from the clearance in solution A.
A B CD
Protein
(60,000 daltons(
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51 mgIlOO ml in solution D). In one patient, os-
molality was measured, and there was a modest but
progressive decrease in drainage osmolality as the
day progressed (from 318.0 0.4mOsmlkg H20 for
the first six exchanges to 310.0 1.2 mOsmlkg H20
for the last six exchanges). This effect was unre-
lated to the presence of nitroprusside and probably
reflects the progressive decrease in BUN over the
course of the day.
Discussion
The microcirculatory experiments in this study
demonstrated that commercially available perito-
neal dialysis solutions are vasoactive. In our models
of both the parietal peritoneum (the cremaster vas-
culature) and the visceral peritoneum (the cecum
vasculature), after a transient constriction or de-
lay, there was a sustained dilation. The prolonged
dilation was reversible when the vessels were
"washed" with Krebs solution. In the clinical ex-
periments (C-I), the clearances for the four solutes
measured were not different among the brands.
Thus, any chemical differences in the composition
of these solutions (Table 1), for instance, lactate in
Inpersol® and Dianeal® vs. acetate in McGaw®, did
not produce any discernible differences in either the
microcirculatory or clinical responses. Also, be-
cause Inpersol® at a pH of 5.8 (solution A) pro-
duced the same responses as Inpersol® adjusted to a
pH of 7.4 (solution B), it is unlikely that the relative-
ly low pH (5.3 to 5.8) of all three commercial perito-
neal dialysis solutions had a significant effect on the
responses to these solutions. Furthermore, the mi-
crocirculatory responses to the drainage solutions
in which pH had partial adjustment by equilibration
with body fluids (Table 3, solutions A and C of
group R-IV) were not distinguishable from the re-
sults obtained with fresh dialysis solution (solutions
A and C of group R-II).
Dwell in the human peritoneum or previous pH
adjustment do not appear to affect the vasoactivity
(constriction followed by dilation) of these dialysis
solutions in the arterioles of the cremaster. In addi-
tion, the arterial vessel in the cecum remained di-
lated after 45 mm of exposure to dialysis solution.
These data indicate that the microvascular effects of
dialysis solutions are unaffected by peritoneal dial-
ysis exchanges and that they have a continuous
dilatory component.
A concentration of nitroprusside which produced
maximal dilation in Krebs solution produced no fur-
ther dilation than did dialysis solution alone in both
the cremaster and cecum arterial vessels. There-
fore, we conclude that dialysis solution produces
maximal dilation of these vessels. The only dif-
ference between sequences with and without nitro-
prusside was the presence of an initial 1- to 2-mm
constriction in the cremaster arterioles or a slow di-
lation in the cecum arteries in the absence of this
vasodilator. Also, in the arterioles of the cremaster,
the microcirculatory effects of the drainage solu-
tions with nitroprusside were the same as were the
effects of these solutions before instillation. Thus,
what appears to be active nitroprusside is still pres-
ent in the dialysate.
The similar microvascular responses to the three
different commercial dialysis solutions (group R-I),
an initial constriction, usually lasting less than 2
mm, and a subsequent dilation for the remainder of
the experimental period, indicate that these re-
sponses must be caused by a factor or factors com-
mon to all three solutions. This factor could be os-
molality (Table 1), because others have shown in-
creased clearances with hyperosmolar solutions [2,
9] which would correlate with dilation of the perito-
neal vasculature. Perfusion studies have demon-
strated a decrease in vascular resistance with hy-
perosmolar solutions [10]. Microcirculatory studies
with the hamster cheek pouch [11] showed dilation
after a 5-mm delay with a hypertonic solution of 332
mOsm/kg H20 and after a 2-mm delay with a solu-
tion of 372 mOsm/kg H20. It is possible that in our
microcirculatory studies the high osmolality of the
commercial dialysis solutions (Table 1) was respon-
sible for the dilation of the arterioles. However, the
time course and magnitude of the dilation we ob-
served in fresh dialysate and in drainage fluid were
very similar despite the lower osmolality of the
drainage fluids (340 vs. approximately 310 mOsmlkg
H20). This suggests that osmolality alone was not
responsible for the dilation of the arterioles.
Acetate or lactate (Table I) are other factors
which could act alone or in concert with osmolality
to produce vasodilation. Acetate has previously
been shown by others to decrease peripheral resis-
tance [13]. Further studies will be necessary to dif-
ferentiate the contribution of these factors to the
microvascular responses to dialysis solutions.
Despite the finding of the same maximal dilation
with the four solutions (A, B, C, and D) in the rat
cremaster arterioles, and two solutions in the cc-
cum arteries, the clinical data (Fig. 5) demonstrate
significant effects of nitroprusside on clearances of
urea, creatinine, and inulin and on the concentra-
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tion of protein. Certainly, if the constrictor re-
sponse or slow dilation to dialysis solution that we
observed in the rat microcirculation was prolonged
in the human peritoneum, and blocked by the addi-
tion of nitroprusside, the increased clearances with
nitroprusside might be explained by an immediate
vasodilatory mechanism. Calculations of mass
transfer coefficients by the method of Bomar et al
[12] suggest that 6 mm of severely reduced blood
flow in the peritoneum that could be blocked by ni-
troprusside could account for the increased clear-
ances that were observed with sodium nitro-
prusside. This would be the equivalent of an effect
of nitroprusside on the area available for solute ex-
change.
Our data are compatible also with the hypothesis
that nitroprusside increases vascular permeability.
In our examination of this question, we compared
relative changes in clearance for the four solutes.
Data for each patient was calculated as a percent of
the value in the control solution A (control In-
persol®), and the mean percent values for each so-
lute in each of the four solutions were determined
(Fig. 5). This figure demonstrates that when sodium
nitroprusside is added to the dialysis solution (solu-
tions C and D) there appears to be a relatively great-
er effect on the higher molecular weight solutes.
When the values for solutions C and D are pooled
and expressed as a percent of those values for solu-
tion A, we find the increased effects to be: urea,
21%; creatinine, 23%; inulin, 36%; and protein,
111%. Selectively greater proportional increases for
larger solutes are compatible with enhanced per-
meability.
An effect of nitroprusside on area or permeability
has also been suggested by Hirszel et a! [14] in dial-
ysis experiments with rabbits. Brown et al [2] con-
cluded from their dialysis data in rats, that nitro-
prusside may increase the area for solute exchange
but not solute permeability. In view of the fact that
no differences in drainage volumes were deter-
mined, there does not appear to be an effect of ni-
troprusside on ultrafiltration that could explain our
current data, and the question of whether the effect
is on area or permeability remains open.
Collectively our data show that dialysis solutions
are vasoactive and that vasoactivity is similar in
both the visceral and parietal vasculatures. The
principal effect of these solutions is vasodilation,
which is not caused by their low pH. This correlates
with our clinical data in which solute clearances do
not change with pH adjustment. Dilation is near
maximal and is not augmented by the addition of
sodium nitroprusside. Transient vasoconstriction is
blocked, and the time to maximal dilation is de-
creased by nitroprusside. These effects represent,
along with an effect to possibly increase per-
meability or area for solute exchange, or both,
mechanisms whereby the addition of sodium nitro-
prusside to dialysis solution could account for the
increased clearances we obtained in peritoneal dial-
ysis.
Acknowledgments
This work was supported in part by Contracts
NO1-AM7 2217 and NOl-AM7 2216 from the Arti-
ficial Kidney Program of the National Institutes of
Arthritis, Metabolism and Digestive Diseases, Na-
tional Institutes of Health. Informed consent was
obtained from all subjects and this research was
carried out according to the Declaration of Hel-
sinki. Dr. R. P. Popovich performed the mass trans-
fer coefficient calculations and David Andersen,
Paul Brown, John Krstansky, Harold Moore, Ran-
dall Sheller, and Wayne Lamm gave technical as-
sistance.
Reprint requests to Dr. F. N. Miller, Dalton Research Center,
University of Missouri, Columbia, Missouri 652/1, USA
References
I. NOLPH KD, GI-IODS AJ, VAN STONE J, BROWN PA: The ef-
fects of intraperitoneal vasodilators on peritoneal clear-
ances. Trans Am Soc Art if Intern Organs 22:586-594, 1976
2. BROWN EA, KL!NGER AS, GOFFINET J, F!NKELSTEIN FO:
Effect of hypertonic dialysate and vaosdilators on pentoneal
dialysis clearances in the rat. Kidney mt 13:271—277, 1978
3. WE! EP, THAMES MD, KONTOS HA, PATTERSON JL JR: Inhi-
bition of the vasodilator effect of hypercapnic acidosis by
hypercalcemia in dogs and rats. Circ Res 35:890-895, 1974
4. MILLER FN, WIEGMAN DL: Anesthesia induced alteration
of small vessel responses to norepinephnne. Eur J Pharma-
col 44:33 1—337, 1977
5. DEVANEY Mi, RATUKE JE, BARTEL RW, MCDONALD JE,
WIEGMAN DL, MILLER FN, HARRIS PD: Continuous mea-
surement of vascular diameters via television microscopy.
Biomed Sci Instrum 11:1—6, 1975
6. WALSER M, DAVIDSON DG, ORLOFF J: The renal clearance
of alakali-stable inulin. J C/in Invest 34:1520—1523, 1955
7. WESTGARD JO, POQUETTE MA: Determination of serum al-
bumin with "SMA 12/60" by a bromocresol green dye-
binding method. Clin Chem 18:647-653, 1972
8. KRAMER CY: Extension of multiple range tests to groups
means with unequal numbers of replications. Biometrics
12:307-310, 1956
Altered peritoneal dialysis solutions 639
9. HENDERSEN LW, NOLPH KD: Altered permeability of the 12. BOMAR JB, DECHERD iF, ILLAVINKA BJ, MANCRIEF JW,
peritoneal membrane after using hypertonic dialysis fluid. J P0P0vIcH RP: The elucidation of maximum efficiency—mm-
Gun Invest 48:992-1001, 1969 imum cost peritoneal dilaysis protocols. Trans Am Soc Artif
Intern Organs 20:120—129, 197410. GRAZITUA S, SCOTT JB, CHou CC, HADDY FJ: Effect of 13. LIANO C, LOWENSTEIN JM: Metabolic control of the circu-
osmolarity on canine renal vascular resistance. Am J Physiol lation. J Clin Invest 62:1029—1038, 1978127: 1216—1223, 1969 14. HIRSZEL P, MAHER iF, CHAMBERLIN M: Augmented perito-
11. DULING BR, STAPLES E: Microvascular effects of hyper- neal mass transport with intraperitoneal nitroprusside. J
tonic solutions in the hamster. Microvasc Res 11:51—56, 1976 Dialysis 2:131—142, 1978
